We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MicroRNA Ratios Differentiate Melanomas from Nevi

By MedImaging International staff writers
Posted on 15 Oct 2019
Print article
Image: MicroRNA sequencing and optical algorithms can detect melanoma cells in skin tumors (Photo courtesy of Rodrigo Torres/ UCSF).
Image: MicroRNA sequencing and optical algorithms can detect melanoma cells in skin tumors (Photo courtesy of Rodrigo Torres/ UCSF).
A new study shows how an optical discrimination platform can detect malignant characteristics in a melanocytic tumor using specific microRNA (miRNA) patterns.

Developed at the University of California, San Francisco (UCSF; USA), the University of Utah (Salt Lake City, USA), and other institutions, the new technique applies a machine learning-based pipeline to a dataset consisting of genetic features, clinical features, and next-generation microRNA sequencing to tissues samples, in order to distinguish melanomas and their adjacent benign precursor nevi. The ML technique can detect eight specific expression ratios of miRNA patterns in the micro-dissected sections.

For the study, the researchers examined 82 biopsy specimens of moles and malignant melanomas, 41 of each type, taken from the medical records of the UCSF dermatopathology section. They then compared the new optical method of detecting malignant melanoma cells with the actual recorded outcomes. The results revealed a sensitivity of 81% and specificity of 88%, which was uninfluenced by either the age of the patient or by the presence of a large amount of benign cells in the same tumor. The study was published on June 20, 2019, in the Journal of Investigative Dermatology.

“We found that by developing a classifier based on a ratio of diagnostically important miRNA we could provide a more robust biomarker that was less susceptible to changes in tumor cell content and platform,” said lead author Rodrigo Torres, PhD, of UCSF. “The advantages of using miRNAs to distinguish benign and malignant melanocytic tumors include the fact that that they are easy to obtain from body fluids, are stable, inexpensive to measure and do not require very invasive techniques or a large amount of tissue.”

A miRNA is a short stretch of non-coding RNA that act to stop the production of protein by the RNA as and when indicated, typically by binding to a part of the RNA which is not involved in protein encoding. The miRNA expression profile variations between tissues, the relationships between them, and genetic and clinical features can help to identify the tissue a tumor originates from.

Related Links:
University of California, San Francisco
University of Utah

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Software
UltraExtend NX
New
Wireless Handheld Ultrasound System
TE Air
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.